Early research (Phase 1)Study completedNCT01065025
What this trial is testing
Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies
Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60